Relationship between glycolipid metabolism and aortic dissection in a hypertensive population: an early diagnostic

Yong Lin1,2,3, Yi-Ting Huang4, Shao-Sheng Wu5

  • 1Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

Insights

This study developed a predictive model for acute type A aortic dissection in hypertensive patients using demographic factors and lipid levels. The model shows good predictive value, aiding in early diagnosis for this high-risk population.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Diagnostic Modeling

Background:

  • The link between glycolipid metabolism and acute type A aortic dissection (aTAAD) in hypertensive patients is not well understood.
  • Hypertension is a significant risk factor for cardiovascular diseases, including aortic dissection.

Purpose of the Study:

  • To establish and validate an early diagnostic model for acute type A aortic dissection in hypertensive individuals.
  • To identify key demographic and glycolipid metabolic factors associated with aTAAD in this population.

Main Methods:

  • A retrospective multi-center study involving hypertensive patients over five years.
  • Development of a diagnostic model using demographic and glycolipid data, with internal training and external validation.
  • Receiver operating characteristic (ROC) analysis and decision curve analysis were used to assess model efficacy.

Main Results:

  • Key risk factors identified include younger age, higher BMI, male sex, absence of diabetes, lower total cholesterol, and higher lipoprotein(a).
  • The model achieved good predictive performance with ROC values of 0.789 (training) and 0.744 (validation).
  • Decision curve analysis indicated the model's clinical utility across a range of threshold probabilities.

Conclusions:

  • A predictive model integrating demographic characteristics and serum lipid profiles demonstrates good predictive value for acute type A aortic dissection in hypertensive patients.
  • This model can aid in the early identification of individuals at high risk for aTAAD, facilitating timely intervention.
Abstract

Related Concept Videos

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...